Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
about
Epithelial-Mesenchymal Transition and Breast CancerThe fate of chemoresistance in triple negative breast cancer (TNBC)Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand ActivityA comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese womenGROα overexpression drives cell migration and invasion in triple negative breast cancer cells.CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.Molecular breast cancer subtypes and therapies in a public hospital of northeastern Brazil.Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapyEnrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisThe bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations.Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women.Descriptive study of triple negative breast cancer in Eastern Algeria.Association of Epithelial Mesenchymal Transition with prostate and breast health disparities
P2860
Q26773055-389858D7-FC86-4340-9983-93D3CE4FD327Q26775232-9C342239-98BF-404E-9776-F8B29AACE0C2Q27345210-8EA2916D-7B8A-4019-B21E-ABCDF75A9399Q33618290-15EC87A9-B772-463F-AC06-88836B2EFBC7Q33858488-9520AF84-1C62-4ECF-9602-91629EB3A620Q33888775-6623B351-A407-4494-8181-8E9D05E1396CQ34196915-23908C1B-88BA-4E13-9746-48BD23028AF3Q34580487-ED6152BB-4DEE-4938-8024-67B475214107Q35271188-8C75C632-0D39-41F2-B24F-B4A0376C194FQ35901372-8AE48ED6-9D46-42DA-884D-EC8839AA952FQ36504123-AD685712-8910-4F3C-80BF-B73A4896B94EQ37702577-93E8EB00-647D-4EAF-AA56-71B0F6CFD6FAQ38375829-91D4D85D-AD7C-4AF1-85C5-52265B600798Q40931689-8B324FD1-9FE9-4F05-9150-2F5A6F23BD07Q53693107-0CA1FB1D-CBC7-4728-A3FF-A82D11D26000Q55358855-6948D1E1-5126-4DDA-B6CB-07C400F1CAC7Q58756554-75029AB8-B5DD-4EE7-BB23-02FBB7F77343
P2860
Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@ast
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@en
type
label
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@ast
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@en
prefLabel
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@ast
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@en
P2093
P2860
P1433
P1476
Triple negative breast tumors ...... CD24+, and have loss of PTEN.
@en
P2093
Jaydutt V Vadgama
Marianna Sarkissyan
Yahya Elshimali
Yanyuan Wu
P2860
P304
P356
10.1371/JOURNAL.PONE.0078259
P407
P577
2013-10-22T00:00:00Z